Is Kimia Bioscien. overvalued or undervalued?

Nov 14 2025 08:07 AM IST
share
Share Via
As of November 13, 2025, Kimia Bioscien. is fairly valued with a PE ratio of 17.26 and an EV to EBITDA ratio of 9.63, but has underperformed in the market with a year-to-date return of -29.9%, despite having a strong ROE of 88.05% compared to its peers.
As of 13 November 2025, the valuation grade for Kimia Bioscien. has moved from attractive to fair, indicating a shift in its perceived value. The company is currently fairly valued, with a PE ratio of 17.26, an EV to EBITDA ratio of 9.63, and an impressive ROE of 88.05%.

In comparison to its peers, Kimia Bioscien. stands out with a lower PE ratio than Sun Pharma. Inds., which is considered expensive at 36.15, and also compares favorably against Aurobindo Pharma, which is rated fair with a PE of 20.65. Despite its fair valuation, Kimia has underperformed in the market, with a year-to-date return of -29.9%, contrasting sharply with the Sensex's gain of 8.11% during the same period.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News